Lotus Bio-Technology Development Corp. engages in improving healthcare and advancing diagnostics through technology development and market acquisition. The company is headquartered in Costa Mesa, California. The company went IPO on 2013-03-14. The firm delivers a series of at-home diagnostic tests that help form a complete picture of their current overall health including hormone levels, allergies, sensitivities, and any pre-existing conditions or infections. Then, based on those results, and a user's interests, lifestyle and goals, an advisor from The Company works with the individual one on one to help customize a wellness plan that incentivizes them to continue caring for their health and reach new goals. Through the Company's at-home diagnostic testing, customizable wellness plans, and strategic partnerships, the Company provides access to healthcare and improve quality of life for its users.
Follow-Up Questions
Lotus Bio-Technology Development Corp 'in CEO'su kimdir?
Mr. Zoltan Nagy 2011 'den beri şirketle birlikte olan Lotus Bio-Technology Development Corp 'in President 'ıdır.
LBTD hissesinin fiyat performansı nasıl?
LBTD 'in mevcut fiyatı $0 'dir, son işlem günde 0% decreased etti.
Lotus Bio-Technology Development Corp için ana iş temaları veya sektörler nelerdir?
Lotus Bio-Technology Development Corp N/A endüstrisine ait ve sektör N/A 'dir
Lotus Bio-Technology Development Corp 'in piyasa değerlemesi nedir?
Lotus Bio-Technology Development Corp 'in mevcut piyasa değerlemesi $0 'dir